This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Hummingbird Diagnostics Gmbh. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Jens Ingwersen: Innovator in Multiple Sclerosis Treatment
Introduction
Jens Ingwersen is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of multiple sclerosis (MS). His innovative approach focuses on utilizing miRNA for monitoring and adjusting therapeutic treatments for patients suffering from this condition.
Latest Patents
Jens Ingwersen holds a patent titled "MiRNA based treatment monitoring in multiple sclerosis." This invention relates to methods for determining patient responses to therapeutic treatments for MS. It also includes monitoring the disease's progression, assessing relapse risks, and adjusting drug dosages based on miRNA levels in patient samples. The patent outlines a comprehensive approach to improving treatment efficacy and patient outcomes in multiple sclerosis.
Career Highlights
Ingwersen is associated with Hummingbird Diagnostics GmbH, where he applies his expertise in developing innovative solutions for medical diagnostics. His work has been instrumental in advancing the understanding of miRNA's role in therapeutic monitoring. With a focus on patient-centered care, he aims to enhance treatment strategies for multiple sclerosis.
Collaborations
Jens Ingwersen collaborates with esteemed colleagues such as Markus Beier and Hans-Peter Hartung. Together, they work towards advancing research and development in the field of multiple sclerosis treatment.
Conclusion
Jens Ingwersen's contributions to the field of multiple sclerosis treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to pave the way for advancements in medical diagnostics and therapeutic strategies.